Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 220, 69120, Heidelberg, Germany.
Cancer Immunol Immunother. 2013 Jan;62(1):27-37. doi: 10.1007/s00262-012-1303-8. Epub 2012 Jun 23.
High-level microsatellite-unstable (MSI-H) colorectal carcinomas (CRC) represent a distinct subtype of tumors commonly characterized by dense infiltration with cytotoxic T cells, most likely due to expression of MSI-H-related frameshift peptides (FSP). The contribution of FSP and classical antigens like MUC1 and CEA to the cellular immune response against MSI-H CRC had not been analyzed so far. We analyzed tumor-infiltrating and peripheral T cells from MSI-H (n = 4 and n = 14, respectively) and microsatellite-stable (MSS) tumor patients (n = 26 and n = 17) using interferon gamma ELISpot assays. Responses against 4 FSP antigens and peptides derived from MUC1 to CEA were compared with and without depletion of regulatory T cells, and the results were related to the presence of the respective antigens in tumor tissue. Preexisting FSP-specific T cell responses were detected in all (4 out of 4) tumor-infiltrating and in the majority (10 out of 14) of peripheral T cell samples from MSI-H CRC patients, but rarely observed in MSS CRC patients. Preexisting T cell responses in MSI-H CRC patients were significantly more frequently directed against FSP tested in the present study than against peptides derived from classical antigens MUC1 or CEA (p = 0.049). Depletion of regulatory T cells increased the frequency of effector T cell responses specific for MUC1/CEA-derived peptides and, to a lesser extent, T cell responses specific for FSP. Our data suggest that the analyzed FSP may represent an immunologically relevant pool of antigens capable of eliciting antitumoral effector T cell responses.
高水平微卫星不稳定(MSI-H)结直肠癌(CRC)代表了一种独特的肿瘤亚型,其特征通常为细胞毒性 T 细胞的密集浸润,这很可能是由于 MSI-H 相关移码肽(FSP)的表达。迄今为止,尚未分析 FSP 以及经典抗原(如 MUC1 和 CEA)对 MSI-H CRC 细胞免疫反应的贡献。我们使用干扰素γ ELISpot 测定法分析了 MSI-H(n=4 和 n=14)和微卫星稳定(MSS)肿瘤患者(n=26 和 n=17)的肿瘤浸润和外周 T 细胞。比较了针对 4 个 FSP 抗原和源自 MUC1 至 CEA 的肽的反应,同时进行了和不进行调节性 T 细胞耗竭,并将结果与肿瘤组织中相应抗原的存在相关联。在所有(4 个中的 4 个)肿瘤浸润性和大多数(14 个中的 10 个)MSI-H CRC 患者的外周 T 细胞样本中均检测到了预先存在的 FSP 特异性 T 细胞反应,但在 MSS CRC 患者中很少观察到。MSI-H CRC 患者预先存在的 T 细胞反应针对本研究中测试的 FSP 的频率明显高于针对源自经典抗原 MUC1 或 CEA 的肽(p=0.049)。调节性 T 细胞的耗竭增加了针对源自 MUC1/CEA 的肽的效应 T 细胞反应的频率,并且在较小程度上增加了针对 FSP 的 T 细胞反应的频率。我们的数据表明,所分析的 FSP 可能代表了一组能够引发抗肿瘤效应 T 细胞反应的免疫相关抗原。